Andrade Lisa 4

What Happened

• Lisa Andrade, a member of NeuroPace's board of directors, received two equity awards on 2026-06-05: a 2,890-share award reported at $0.00 per share and a 5,368-share derivative award (an option/derivative security) also reported at $0.00 per share. Both grants were reported as acquisitions (code A) on the Form 4.
• The filings show no cash paid for these awards (transaction price $0.00). These are compensation grants — not open‑market purchases or sales — so they do not represent an immediate buy/sell market signal.

Key Details

• Transaction date: 2026-06-05; Report filed same day (timely).
• Grants: 2,890 shares (award) and 5,368 shares (derivative/option); both reported at $0.00 per share.
• Vesting: Both awards vest in twelve (12) equal consecutive monthly installments, subject to continuous service (footnotes F1 and F2).
• Shares owned after transaction: Not specified in the provided data.
• Transaction codes: A = Award/Grant (derivative designation indicates option-like award). No 10b5-1, tax‑withholding, or late-filing notes in the provided details.

Context

• The 5,368-share derivative is an option-like grant that will become exercisable as it vests; exercising would be a separate taxable/transaction event and would be reported separately when it occurs.
• Director equity grants are routine compensation and do not, by themselves, indicate a director buying or selling stock for investment reasons.